Last updated: July 10, 2026

Application No. 19/328,308

Untitled Application

Unknown

Filed

Priority

Nov 30, 2023 — EU 23213366.0 +1 more

Examiner

HA, JULIE

Art Unit

Tech Center

Novo Nordisk A/S

Assignee

Novo Nordisk Inc.

OA Round

1 (Non-Final)

Interview Optional

— +44.4% interview lift. Examiner has a relatively high allowance rate (76%); +44.4% interview lift. A written response may suffice.

Based on 1111 resolved cases, 2023–2026

Examiner Intelligence

HA, JULIE View full profile →

Grants 76% — above average

Career Allowance Rate

840 granted / 1111 resolved

+15.6% vs TC avg

Strong +44% interview lift

Without

With

+44.4%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

45 currently pending

Career history

1158

Total Applications

across all art units

Statute-Specific Performance

§101

3.6%

-36.4% vs TC avg

§103

32.2%

-7.8% vs TC avg

§102

17.0%

-23.0% vs TC avg

§112

21.7%

-18.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1111 resolved cases

Prosecution Timeline

Jun 18, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/068,387

Patent 12673084

COMPOSITIONS AND METHODS FOR COMBINATORIAL DRUG DISCOVERY IN NANOLITER DROPLETS

3y 6m to grant Granted Jul 07, 2026

18/527,006

Patent 12673974

ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES

2y 7m to grant Granted Jul 07, 2026

17/514,906

Patent 12653867

LYOPHILIZED RECOMBINANT VWF FORMULATIONS

4y 7m to grant Granted Jun 16, 2026

18/602,421

Patent 12649900

PHOTOSTABILIZED COMPOSITIONS AND A METHOD FOR STABILIZING PHOTOSENSITIVE COMPONENTS

2y 2m to grant Granted Jun 09, 2026

17/761,496

Patent 12622975

PEPTIDE-CONJUGATED PRODRUGS

4y 1m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

76%

Grant Probability

99%

With Interview (+44.4%)

2y 7m

Median Time to Grant

Low

PTA Risk

Based on 1111 resolved cases by this examiner. Grant probability derived from career allowance rate.